AI-CVD vs OMRON VitalSight

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung AI

OMRON VitalSight

by OMRON Healthcare

AI Verdict

While both tools contribute to cardiovascular health, their core functionalities are distinct. AI-CVD focuses on opportunistic screening and early detection of various cardiovascular and multisystem diseases by analyzing existing CT scans. OMRON VitalSight, conversely, is a remote patient monitoring service designed specifically for managing hypertension through connected blood pressure devices and data integration.

Choose AI-CVD if…

Choose AI-CVD if your organization aims to opportunistically screen for hidden cardiovascular and multisystem disease risks by leveraging existing CT scan data. This platform is ideal for enhancing early detection without requiring additional imaging, radiation, or disrupting current clinical workflows, providing comprehensive quantitative measurements from already acquired scans.

View AI-CVD →

Choose OMRON VitalSight if…

Choose OMRON VitalSight if your practice requires a dedicated remote patient monitoring service for the ongoing management of hypertension and improving patient outcomes. This solution is best suited for actively monitoring diagnosed hypertensive patients, offering seamless EHR integration and automatic alerts for out-of-range readings through convenient, pre-set at-home devices.

View OMRON VitalSight →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	OMRON VitalSight
Pricing	Unknown	Reimbursement-based
Deployment	Unknown	Cloud-based (physician dashboard) with at-home patient devices.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

OMRON VitalSight

OMRON VitalSight prioritizes ease of use for patients with pre-set devices, a data hub that operates without Wi-Fi or cellular connection, and direct home delivery of kits. For clinicians, it offers seamless EHR/EMR integration or dashboard access. While AI-CVD integrates well into existing radiology workflows, VitalSight's comprehensive approach to patient and clinician usability gives it an edge.

Clinical Value

AI-CVD

AI-CVD is an FDA-cleared platform that performs opportunistic screening for a broad range of cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. It provides quantitative measurements for numerous indicators like CAC scoring, cardiac chamber volumetry, and bone mineral density, offering a wider scope of early disease detection from a single, already performed scan. OMRON VitalSight, while valuable for hypertension management, focuses on a more specific condition.

Pricing & Value

OMRON VitalSight

OMRON VitalSight offers transparent pricing, stating it is reimbursement-based, Medicare reimbursable, and generally incurs little to no cost for patients or setup/device costs for physicians. This clear and favorable financial model provides a strong value proposition. AI-CVD's pricing requires contacting the vendor, indicating less transparency.

Enterprise Readiness

OMRON VitalSight

OMRON VitalSight explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside robust EHR/EMR integration capabilities. These are crucial assurances for enterprise adoption and data security. AI-CVD's compliance claims are listed as 'likely, contact vendor,' suggesting less immediate transparency for large-scale deployment.

Innovation

AI-CVD

AI-CVD demonstrates significant innovation by leveraging AI to perform opportunistic screening for multiple diseases from existing CT scans, extracting new, comprehensive clinical insights without additional imaging or workflow disruption. This re-purposing of already acquired data for broad-spectrum early detection represents a more novel application of AI in healthcare. OMRON VitalSight, while a robust RPM solution, operates within a more established technological framework.

Support & Docs

OMRON VitalSight

OMRON Healthcare provides readily accessible user guides, instruction manuals, and customer service contact information for its VitalSight product and other devices. This clear availability of support resources is a strong advantage. Specific support and documentation details for AI-CVD were not readily found through web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	OMRON VitalSight
Name	AI-CVD	OMRON VitalSight
Company	HeartLung Corporation	OMRON Healthcare
Primary Function	AI-powered quantitative imaging platform for opportunistic screening for cardiovascular and multisystem diseases using existing CT scans.	Remote patient monitoring service for hypertension management using connected blood pressure monitors and data hubs.
Key Data Source	Existing chest and abdominal CT scans	Connected blood pressure monitor and data hub kit
Example Key Feature	Coronary Artery Calcium (CAC) scoring	Remote blood pressure monitoring

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and OMRON VitalSight.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the clinical application and purpose of AI-CVD compared to OMRON VitalSight?

AI-CVD is an AI-powered quantitative imaging platform designed for opportunistic screening of cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. OMRON VitalSight is a remote patient monitoring service focused on managing hypertension through connected blood pressure monitors and secure data integration with EHRs to improve patient outcomes.

How do these tools integrate into a physician's existing workflow and what type of data do they utilize?

AI-CVD integrates by analyzing existing chest and abdominal CT scans, providing automated anatomical and density-based measurements without requiring additional imaging or workflow disruption. OMRON VitalSight integrates securely with EHRs or via a dedicated dashboard, utilizing remote blood pressure readings from patient-operated at-home devices.

What are the financial implications for a physician's practice when considering each tool?

For AI-CVD, physicians need to contact HeartLung Corporation directly for pricing information. OMRON VitalSight is reimbursable through Medicare, generally has little to no cost to the patient depending on coverage, and involves no setup or device costs for physicians, offering an easy claim-reporting process.

Do these tools require any additional patient procedures or in-office equipment for their operation?

AI-CVD performs analysis using existing CT scans, meaning no additional imaging, radiation, contrast, or workflow disruption is required from the patient or practice. OMRON VitalSight provides patients with pre-set connected blood pressure monitor and data hub kits that are delivered directly to their homes for self-monitoring, operating without requiring Wi-Fi or cellular connection for data transmission.

What specific cardiovascular measurements or conditions do these tools help manage or detect?

AI-CVD offers automated CT-derived measurements including Coronary Artery Calcium (CAC) scoring, aortic wall, aortic valve, and mitral valve calcium analysis, cardiac chamber volumetry, and epicardial fat volumetry for early disease detection. OMRON VitalSight focuses on remote blood pressure monitoring with personalized thresholds to manage hypertension and improve patient outcomes.